Open AccessEffect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease
Author(s) -
Alireza Atri,
Lutz Frölich,
Clive Ballard,
Pierre N. Tariot,
José Luís Molinuevo,
Neli Boneva,
Kristian Windfeld,
Lars Lau Rakêt,
Jeffrey L. Cummings
Publication year - 2018
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2017.20373
Subject(s) - donepezil , medicine , rivastigmine , dementia , placebo , galantamine , alzheimer's disease , adverse effect , randomized controlled trial , clinical global impression , clinical trial , disease , pathology , alternative medicine
New therapeutic approaches for Alzheimer disease (AD) are needed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom